The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Tenenbaum Fabian since 2016.
The trader's CIK number is 1641300.
At the time of the last reporting, Tenenbaum Fabian was the Chief Executive Officer of Bellerophon Therapeutics, Inc.. (stock ticker symbol BLPH).
Also see all insider trading activities at Bellerophon Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | BLPH | 5,000 | $2,975 | 0 | $0 | 0 | $0 |
| 2016 | BLPH | 142,857 | $0 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-21 | BLPH | Buy | 5,000 | .59 | 2,975 |
| 2016-11-29 | BLPH | Buy | 142,857 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tenenbaum Fabian (Chief Executive Officer of Bellerophon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.